Skip to main content
Erschienen in: Journal of Neurology 8/2009

01.08.2009 | Original Communication

Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus

verfasst von: Laura B. Zahodne, Michael S. Okun, Kelly D. Foote, Hubert H. Fernandez, Ramon L. Rodriguez, Samuel S. Wu, Lindsey Kirsch-Darrow, Charles E. Jacobson IV, Christian Rosado, Dawn Bowers

Erschienen in: Journal of Neurology | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

While deep brain stimulation (DBS) surgery is a well-accepted treatment for Parkinson disease (PD) that improves overall quality of life (QoL), its effects across different domains of QoL are unclear. The study reported here directly compared the effects of unilateral DBS in subthalamic nucleus (STN) or globus pallidus (GPi) on QoL in 42 non-demented patients with medication-refractory PD. Patients were enrolled in the COMPARE trial, a randomized clinical trial of cognitive and mood effects of STN versus GPi DBS conducted at the University of Florida Movement Disorders Center. Patients underwent motor, mood, verbal fluency and QoL (Parkinson disease questionnaire: PDQ-39) measures before and 6 months following surgery. Groups experienced motor and mood improvements that did not differ by target. Patients with STN DBS evidenced a slight decrement on letter fluency. On average, all patients endorsed better overall QoL after surgery. However, despite similar motor and mood improvements, GPi patients improved more than STN patients (38 vs. 14%, respectively; P = 0.03). Patients reported better QoL on subscales of mobility, activities of daily living (ADLs), emotional well-being, stigma, cognition and discomfort, but not on those of social support and communication. Improvements on the mobility, ADLs, stigma and social support subscales were greater amongst GPi patients. In regression analyses, only depression changes independently predicted changes in overall QoL as well as emotional well-being and social support changes. Within the STN group only, declining category fluency scores correlated with poorer QoL on the communication subscale. Unilateral DBS in both STN and GPi improved QoL overall and in disparate domains 6 months after surgery. Patients receiving GPi DBS reported greater improvements that cannot be explained by differential mood or motor effects; however, verbal fluency changes may have partially contributed to lesser QoL improvements amongst STN patients.
Literatur
1.
Zurück zum Zitat Alberts JL, Hass CJ, Vitek JL, Okun MS (2008) Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease. Exp Neurol 214:1–5. 10.1016/j.expneurol.2008.07.019 Alberts JL, Hass CJ, Vitek JL, Okun MS (2008) Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease. Exp Neurol 214:1–5. 10.​1016/​j.​expneurol.​2008.​07.​019
3.
Zurück zum Zitat Beck AT, Steer R, Brown G (1996) The Beck Depression Inventory-II. Psychological Corporation, San Antonio Beck AT, Steer R, Brown G (1996) The Beck Depression Inventory-II. Psychological Corporation, San Antonio
4.
Zurück zum Zitat Deuschl G, Schade-Bittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K et al (2006) A randomized trial of deep brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908. doi:10.1056/NEJMoa060281 PubMedCrossRef Deuschl G, Schade-Bittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K et al (2006) A randomized trial of deep brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908. doi:10.​1056/​NEJMoa060281 PubMedCrossRef
6.
Zurück zum Zitat Drapier S, Raoul S, Drapier D, Leray E, Lallement F, Rivier I et al (2005) Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson’s disease. J Neurol 252:583–588. doi:10.1007/s00415-005-0704-4 PubMedCrossRef Drapier S, Raoul S, Drapier D, Leray E, Lallement F, Rivier I et al (2005) Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson’s disease. J Neurol 252:583–588. doi:10.​1007/​s00415-005-0704-4 PubMedCrossRef
7.
Zurück zum Zitat Global Parkinson’s Disease Survey Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17:60–67. doi:10.1002/mds.10010 CrossRef Global Parkinson’s Disease Survey Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17:60–67. doi:10.​1002/​mds.​10010 CrossRef
8.
Zurück zum Zitat Gronchi-Perrin A, Viollier S, Ghika J, Combremont P, Villemure JG, Bogousslavsky J et al (2006) Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson’s disease? Mov Disord 21:1465–1468. doi:10.1002/mds.20943 PubMedCrossRef Gronchi-Perrin A, Viollier S, Ghika J, Combremont P, Villemure JG, Bogousslavsky J et al (2006) Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson’s disease? Mov Disord 21:1465–1468. doi:10.​1002/​mds.​20943 PubMedCrossRef
9.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. doi:10.1136/jnnp.55.3.181 PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. doi:10.​1136/​jnnp.​55.​3.​181 PubMedCrossRef
10.
Zurück zum Zitat Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N (1997) The Parkinson’s disease questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357. doi:10.1093/ageing/26.5.353 PubMedCrossRef Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N (1997) The Parkinson’s disease questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357. doi:10.​1093/​ageing/​26.​5.​353 PubMedCrossRef
11.
Zurück zum Zitat Just H, Ostergaard K (2002) Health-related quality of life in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 17:539–545. doi:10.1002/mds.10111 PubMedCrossRef Just H, Ostergaard K (2002) Health-related quality of life in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 17:539–545. doi:10.​1002/​mds.​10111 PubMedCrossRef
12.
Zurück zum Zitat Kirsch-Darrow L, Mikos A, Bowers D (2008) Does deep brain stimulation induce apathy in Parkinson’s disease? Front Biosci 13:5316–5322PubMed Kirsch-Darrow L, Mikos A, Bowers D (2008) Does deep brain stimulation induce apathy in Parkinson’s disease? Front Biosci 13:5316–5322PubMed
13.
Zurück zum Zitat Martínez-Martín P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, Rumià J et al (2002) Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord 17:372–377. doi:10.1002/mds.10044 PubMedCrossRef Martínez-Martín P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, Rumià J et al (2002) Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord 17:372–377. doi:10.​1002/​mds.​10044 PubMedCrossRef
14.
Zurück zum Zitat Mattis S (2001) Dementia Rating Scale-2. Psychological Assessment Resources, Odessa Mattis S (2001) Dementia Rating Scale-2. Psychological Assessment Resources, Odessa
15.
Zurück zum Zitat Montel SB, Bungener C (2008) Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus. Surg Neurol (in press) Montel SB, Bungener C (2008) Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus. Surg Neurol (in press)
16.
Zurück zum Zitat Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F et al. (2009) Cognition and mood in Parkinson disease in STN versus GPi DBS: the COMPARE trial. Ann Neurol (in press) Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F et al. (2009) Cognition and mood in Parkinson disease in STN versus GPi DBS: the COMPARE trial. Ann Neurol (in press)
18.
Zurück zum Zitat Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H et al (2006) Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66:983–995. doi:10.1212/01.wnl.0000215250.82576.87 PubMedCrossRef Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H et al (2006) Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66:983–995. doi:10.​1212/​01.​wnl.​0000215250.​82576.​87 PubMedCrossRef
20.
Zurück zum Zitat Perozzo P, Rizzone M, Bergamasco B, Castelli L, Lanotte M, Tavella A et al (2001) Deep brain stimulation of subthalamic nucleus: behavioural modifications and familiar relations. Neurol Sci 22:81–82. doi:10.1007/s100720170057 PubMedCrossRef Perozzo P, Rizzone M, Bergamasco B, Castelli L, Lanotte M, Tavella A et al (2001) Deep brain stimulation of subthalamic nucleus: behavioural modifications and familiar relations. Neurol Sci 22:81–82. doi:10.​1007/​s100720170057 PubMedCrossRef
21.
Zurück zum Zitat Peto V, Jenkinson C, Fitzpatrick R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248. doi:10.1007/BF02260863 PubMedCrossRef Peto V, Jenkinson C, Fitzpatrick R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248. doi:10.​1007/​BF02260863 PubMedCrossRef
22.
Zurück zum Zitat Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL (2007) Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson’s disease. Mov Disord 22:1866–1870. doi:10.1002/mds.21427 PubMedCrossRef Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL (2007) Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson’s disease. Mov Disord 22:1866–1870. doi:10.​1002/​mds.​21427 PubMedCrossRef
25.
Zurück zum Zitat Sudhyadhom A, Bova FJ, Foote KD, Rosado CA, Kirsch-Darrow L, Okun MS (2007) Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications. Curr Neurol Neurosci Rep 7:278–289. doi:10.1007/s11910-007-0043-1 PubMedCrossRef Sudhyadhom A, Bova FJ, Foote KD, Rosado CA, Kirsch-Darrow L, Okun MS (2007) Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications. Curr Neurol Neurosci Rep 7:278–289. doi:10.​1007/​s11910-007-0043-1 PubMedCrossRef
26.
Zurück zum Zitat The Deep-Brain Stimulation for Parkinson’s Disease Study Group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 345:956–963. doi:10.1056/NEJMoa000827 CrossRef The Deep-Brain Stimulation for Parkinson’s Disease Study Group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 345:956–963. doi:10.​1056/​NEJMoa000827 CrossRef
29.
Zurück zum Zitat Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO et al (2008) Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomized, multicentre study. Lancet Neurol 7:605–614. doi:10.1016/S1474-4422(08)70114-5 PubMedCrossRef Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO et al (2008) Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomized, multicentre study. Lancet Neurol 7:605–614. doi:10.​1016/​S1474-4422(08)70114-5 PubMedCrossRef
30.
Zurück zum Zitat Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L et al (2009) Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change. Clin Neuropsychol 23(3):385–405PubMedCrossRef Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L et al (2009) Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change. Clin Neuropsychol 23(3):385–405PubMedCrossRef
Metadaten
Titel
Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus
verfasst von
Laura B. Zahodne
Michael S. Okun
Kelly D. Foote
Hubert H. Fernandez
Ramon L. Rodriguez
Samuel S. Wu
Lindsey Kirsch-Darrow
Charles E. Jacobson IV
Christian Rosado
Dawn Bowers
Publikationsdatum
01.08.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 8/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5121-7

Weitere Artikel der Ausgabe 8/2009

Journal of Neurology 8/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.